API Holdings Directly Vests 51.02% Stake in Thyrocare Post-Amalgamation
Thyrocare Technologies Ltd 路 Acquisition/ Disposal of Shares 路 04 Sept 2026, 8:29 pm
API Holdings Directly Vests 51.02% Stake in Thyrocare Post-Amalgamation API Holdings has directly acquired an 8,12,00,000 equity shareholding (51.02% of paid-up capital, 50.87% diluted) in Thyrocare Technologies following the NCLT-sanctioned merger of Docon Technologies into API Holdings. The scheme became effective on 3rd Sep'26 upon filing with the RoC, following NCLT approval on 31st Aug'26. As Docon stands amalgamated, its entire Thyrocare stake transferred to API Holdings by operation of law, resulting in no change in the overall promoter group aggregate shareholding.
Original exchange filing (PDF)
More announcements from Thyrocare Technologies Ltd
- Please find the enclosed announcement. 路 06 Nov 2026
- Please find the enclosed intimation. 路 06 Nov 2026
- Please find attached the Earnings Call Transcript held on October 29, 2026 路 02 Nov 2026
- Please find attached Intimation regarding the Execution of Share Purchase Agreement 路 30 Oct 2026
- Audio Recording of Earnings Conference Call for the Quarter and Half Year Ended September 30, 2026 路 30 Oct 2026
- Please find attached the Investor Presentation on the unaudited financial results (standalone and consolidated) for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Please find attached the Press Release on the unaudited financial results (Standalone and Consolidated) for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Please find enclosed the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
